Hongya Xie

461 citations
19 papers · 329 indexed · h-index 8
Topics
Lung Cancer Diagnosis and Treatment (5 papers)RNA modifications and cancer (4 papers)Pleural and Pulmonary Diseases (3 papers)
Partner nations
China

In The Last Decade

Hongya Xie

17 papers receiving 329 citations

Peers

Hongya Xie
Comparison fields: 5 of 56
  • Molecular Biology 175
  • Cancer Research 149
  • Pulmonary and Respiratory Medicine 91
  • Oncology 47
  • Surgery 46
Replace Ruicheng Wu with:
Ruicheng Wu China
Brianna Cyr United States
Sanyuan Zhang China
Dongyu Ma China
Sebastian Vencken Ireland
Marjon Buscop‐van Kempen Netherlands
Wanqiong Yuan China
Thomas Wittmann Germany
Mara Stellato Switzerland
Seema Gupta India
Hongya Xie relative to Ruicheng Wu China Ruicheng Wu's profile →
Citations per field
00.5×10×20×30×38×
Ruicheng Wu · 1×
Citations per year

Countries citing papers authored by Hongya Xie

Since Specialization
Citations

This map shows the geographic impact of Hongya Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongya Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongya Xie more than expected).

Fields of papers citing papers by Hongya Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongya Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongya Xie. The network helps show where Hongya Xie may publish in the future.

Co-authorship network of co-authors of Hongya Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Hongya Xie. A scholar is included among the top collaborators of Hongya Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongya Xie. Hongya Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1
Progranulin modulates the progression of non-small cell lung cancer through lncRNA H19.
2
2 2
3 6
4 125
5 3
6 0
7 7
8 44
9 23
10 1
11 9
12 4
13 35
14 9
15 2
16 0
17
[Single-port VATS resection for some pulmonary diseases:strategies of the incision location in different gender].
1
18 38
19 18

About Hongya Xie

Hongya Xie is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 19 papers that have together received 329 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), RNA modifications and cancer (4 papers) and Pleural and Pulmonary Diseases (3 papers). The work is most often cited by research in Cancer Research (149 citations), Endocrine and Autonomic Systems (29 citations) and Aging (5 citations). Hongya Xie has collaborated with scholars based in China. Frequent co-authors include Bin Ni, Jie Yao, Yuxuan Wang, Donglin Zhu, Yimeng Zhu, Yong Yang, Kai Xu, Jun Zhao, Yong Yang and Qun Wang. Their work appears in journals such as PLoS ONE, Journal of Surgical Research and Aging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026